硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 DCUN1D1 抗体对
试剂盒

抗人 DCUN1D1 抗体对

01AB03333

Defective in cullin neddylation 1 domain containing 1 (DCUN1D1) is a cytosolic and nucleoplasmic adaptor that functions as an accessory E3 ligase within the NEDD8 neddylation pathway. It facilitates the activation of cullin-RING ubiquitin ligases by binding to cullin-RBX1 complexes, the NEDD8-conjugating enzyme UBE2M, and CAND1. This interaction promotes the nuclear translocation of these complexes and enhances cullin neddylation, thereby regulating protein ubiquitination and cell-cycle proteostasis. DCUN1D1 contains a C-terminal PONY domain essential for its E3 activity and an N-terminal UBA domain that serves as a negative feedback regulator. Clinically, DCUN1D1 is frequently amplified and overexpressed in squamous cell carcinomas of the head, neck, and lung. In these contexts, it acts as an oncogene that drives tumor proliferation, invasion, and overall aggressiveness.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
DCUN1D1
基因别名
DCN1; DCUN1L1; RP42; SCCRO
蛋白别名
defective in cullin neddylation 1 domain containing 1; DCUN1D1
UniProt
Q96GG9
物种
Human

产品详情

靶点名称
DCUN1D1
蛋白名称
defective in cullin neddylation 1 domain containing 1
蛋白别名
DCN1-like protein 1; DCNL1; DCUN1 domain-containing protein 1; Defective in cullin neddylation protein 1-like protein 1; Squamous cell carcinoma-related oncogene
靶点基因名
DCUN1D1
基因别名
DCN1; DCUN1L1; RP42; SCCRO
UniProt
Q96GG9
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Defective in cullin neddylation 1 domain containing 1 (DCUN1D1) is a cytosolic and nucleoplasmic adaptor that functions as an accessory E3 ligase within the NEDD8 neddylation pathway. It facilitates the activation of cullin-RING ubiquitin ligases by binding to cullin-RBX1 complexes, the NEDD8-conjugating enzyme UBE2M, and CAND1. This interaction promotes the nuclear translocation of these complexes and enhances cullin neddylation, thereby regulating protein ubiquitination and cell-cycle proteostasis. DCUN1D1 contains a C-terminal PONY domain essential for its E3 activity and an N-terminal UBA domain that serves as a negative feedback regulator. Clinically, DCUN1D1 is frequently amplified and overexpressed in squamous cell carcinomas of the head, neck, and lung. In these contexts, it acts as an oncogene that drives tumor proliferation, invasion, and overall aggressiveness.